Dr Datsons Labs to supply anti-malarial drugs to Yemen

The order is estimated to be about Rs 80 crore


(Photo Courtesy: www.thehindu.com)

Dr Datsons Labs announced that it has signed a marketing and distribution deal with Yemen's Al-Mugdh Pharma to sell its anti-malarial drugs in Yemen.

The order is estimated to be about Rs 80 crore, said the company in its filing to BSE.

Mr Sameer Talim, CEO, Dr Datsons Labs, commented, "The talk between the two companies was going on for last six months and there are certain regulatory aspects that need to be addressed before the commercialization of the 5 products to be exported to Al-Mugdh Pharma."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email